A non-small cell lung carcinoma patient responded to crizotinib therapy after alectinib-induced interstitial lung disease
Crossref DOI link: https://doi.org/10.3724/zdxbyxb-2023-0319
Published Online: 2023-10-27
Published Print: 2023-10-01
Update policy: https://doi.org/10.1360/scp-crossmark-policy-page
SUN, Wenjia
ZHENG, Jing
ZHOU, Jianya
ZHOU, Jianying
